READ ALSO 7 Best Stocks ... company’s share price.” A caller recently asked Jim Cramer about PepsiCo Inc (NASDAQ:PEP). Cramer said the stock is under threat from weight-loss drugs.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The increase in weight loss ... semaglutide products – Ozempic and Rybelsus for type 2 diabetes – have been included on the list of the next 15 drugs to be subject to what the government calls ...

Lizzo is feeling "Good as Hell" as she celebrates a major milestone in her weight loss journey. The "About Damn Time" singer, 36, shared Saturday on Instagram that she has "reached my weight ...

In response to this, Morrisons, in partnership with online prescription delivery service Phlo, has launched its own on-demand healthcare service, Morrisons Clinic. Here, you can swiftly and easily ...

Catering to this, and in partnership with online prescription delivery service Phlo, Morrisons has launched its own on-demand healthcare service, Morrisons Clinic, where you can quickly and easily ...

Katie Price has got ready to take her looks to next level as she headed to Turkey, amid rising concerns over her drastic weight loss. The 48-year-old shared a video, donning light blue track suit ...

Katie Price donned ... She's done the lips at The Clinic Club. I just love it here, I'm obsessed with them here.' Discussing her latest plans while addressing her weight loss, Katie continued ...

Katie Price has shared ... done the lips at The Clinic Club. I just love it here, I'm obsessed with them here.' Discussing her latest plans while addressing her weight loss, Katie continued ...

Dyck and his team focused their research on Ozempic, a widely used weight-loss medication, to better understand its reported side effect of skeletal muscle loss. Ozempic, known medically as ...

Findings showed semaglutide 7.2mg demonstrated a statistically significant and superior weight loss compared with placebo at week 72. Topline data were announced from a phase 3b trial evaluating ...